Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:m.limatoxi.com >> EN >> Pharmaceutical News
Xuezhikang starts Phase Ⅱ clinical trials in USA2011-01-17
SFDA vows to insure quality of essential medicine2011-01-14
Hegno plans to produce Vitamin E since May2011-01-14
Jiangsu Dolphin is building new Cephalosporines facility2011-01-13
United Laboratories will enter insulin market2011-01-12
Aurobindo sells stake to Sinopharm2011-01-12
Hegno is building Vitamin E project2011-01-11
South Africa maintains antidumping duty for Chinese paracetamol2011-01-10
Hayao passed GMP for 5 antibiotic mixed powders2011-01-10
Biopharmaceutical colony formed in Inner Mongolia2011-01-07
CSPC's sales revenue reaches 13 bln Yuan in 20102011-01-07
Prevalence of obesity will significantly increase in China2011-01-06
Golden Meditech listed TDR on TSE2011-01-05
Prices of essential drugs decrease by about 30%2011-01-05
Kindomway newly got 3 export approvals2011-01-04
China will implement export license for 3 APIs2011-01-04
NCPC's sales revenue exceeds 10 billion Yuan in 20102011-01-04
Big consumption of intravenous infusions in China2011-01-04
Sinovac commences clinical trial of inactivated enterovirus vaccine2010-12-31
Domestic margin level in first 11 months2010-12-30
Fosun and Chindex form JV to explore medical device market2010-12-30
Guangji Pharma boosts Vitamin B2 export steadily2010-12-29
Huasheng passed FDA's spot examinations for several products2010-12-29
Orphan drug Kuvan approved for PKU in China2010-12-28
Irassa certified as frontier NSCLC drug2010-12-27
Zhejiang Garden prolongs its VD3 product portfolio2010-12-24
Import value of Anesthesia equipments increases by 35.98% in China2010-12-24
Market activities of healthcare giants in China2010-12-23
Topfound started to build APIs project in Zhumadian2010-12-23
New Cephalosporines project settles Xiangcheng2010-12-22
China and Taiwan sign drug development pact2010-12-22
Growth speed of anti-infection drugs will slow down2010-12-21
共4532个 页次:104/142页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
Baidu
map